Odesa National Medical University MH of Ukraine, Odesa, Ukraine,
Odesa separated subdivision of State Institution “Laboratory Center for Railway Transport of the Ministry of Health of Ukraine”, Odesa, Ukraine
DOI 10.54229/2226-2008-2021-6-10
Visceral obesity plays an important role in chronic inflammation in asthma patients. This is due to the hormonal activity of visceral fat. The visceral adipose tissue (VAT) level is assessed using a number of methods, each of which has its own pros and cons. This study aimed to explore the associations of VAT tissue measured by bioelectrical impedance analysis with lipid metabolism and FEV1 in patients with asthma.
Materials and methods. The study included 42 patients with asthma aged 19–52 years. The anthropometric parameters, lipid metabolism, VAT have been assessed. We used bioelectrical impedance analysis (BEI) to evaluate VAT level.
Results. High levels of VAT were associated with increased levels of TG, total cholesterol, LDL, decreased levels of HDL. With an increase in VAT by 1% should expect a decrease in FEV1 by 1.08%. 43% of overweight patients had elevated VAT levels. At the same time, in 18% of obese patients, according to BMI, increased visceral fat was not detected.
Conclusions. Visceral obesity is associated with the decrease of FEV1 and dyslipidemia of patients with asthma. It is recommended to include the level of VAT by BIA measurement method, in patients with asthma in the algorithms of the medical care to reduce the hypodiagnosis of visceral obesity in individuals with normal and subnormal BMI.
Key words: bronchial asthma, visceral obesity, general obesity, visceral adipose tissue, bioelectrical impedance analysis.
REFERENCES
- Peters U, Dixon AE, Forno E. Obesity and asthma. Journal of Allergy and Clinical Immunology. 2018;141(4): 1169-1179.
- Gomez-Llorente MA, Romero R, Chueca N, Martinez-Canavate A, Gomez-Llorente C. Obesity and Asthma: A Missing Link. International Journal of Molecular Sciences. 2017;18(7). DOI: 10.3390/ijms18071490.
- Thompson CA, Eslick SR, Berthon BS. Asthma medication use in obese and healthy weight asthma: systematic review/meta-analysis. European Respiratory Journal. 2020;57(3). DOI: 10.1183/13993003.00612-2020.
- World Health Organization. Obestiy and Overweight. Fact Sheet. 2016; 311. Available from: http://www.who.int/mediacentre/factsheets/fs311/en/.
- Chumakova HA, Veselovskaia N.H., Grytsenko OV, Ott AV. Metabolic syndrome: challenging and unsolved problems. Rossiyskiy Kardiologicheskiy Zhurnal. 2014;3:63-71. (In Russian).
- Yang MS, Choi S, Choi Y, Jin K.N. Association Between Airway Parameters and Abdominal Fat Measured via Computed Tomography in Asthmatic Patients. Allergy Asthma Immunol Res. 2018;10(5):503-515.
- Deng K, Zhang X, Liu Y. et al. Visceral obesity is associated with clinical and inflammatory features of asthma: A prospective cohort study. Allergy and Asthma Proceedings. 2020; 41(5):348-356. DOI: 10.2500/aap.2020.41.200054
- Jiang D, Wang L, Bai C, Chen O. Association between abdominal obesity and asthma: A meta-analysis. Allergy Asthma and Clinical Immunology. 2019;15(16). DOI: 10.1186/s13223-019-0333-6
- Goudarzi H, Konno S, Kimura H. et al. Impact of Abdominal Visceral Adiposity on Adult Asthma Symptoms. The Journal of Allergy and Clinical Immunology: In Practice. 2019;7(4):1222-1229.
- Borodkyna DA, Gruzdeva OV, Kvytkova LV, Barbarash OL. Is visceral obesity the cause of obesity paradox? Problemy Endokrinologii. 2016; 62(6):33-39. (In Russian)
- Myklyshanskaia SV, Zolozova EA, Safyullyna AA, Mazur NA. Visceral obesity in patients with various body mass index. Lechaschi Vrach. 2020;(8):66-70. (In Russian). Avaliable from: https://doi.org/10.26295/OS.2020.19.39.011 (In Russian)
- Okorokov PL, Vasiukova OV, Vorontsov AV. The methods for the characteristic of adipose tissue in the organism and their clinical significance. Problemy Endokrinologii. 2014;60(3):53-58. (In Russian)